Tempus AI: Is TEM Stock A 10x Growth Story?
1. Tempus AI received FDA approval for its upgraded cardiac imaging platform. 2. The company projects revenue growth of 90% year-over-year for 2025. 3. Tempus plans to capitalize on a $800 billion AI healthcare market by 2030. 4. It's expanding into cardiology, radiology, and mental health, enhancing growth prospects. 5. Despite potential, risks include regulatory hurdles and intense competition.